TRAINING, EDUCATION
Cooperative European Medicines Development Course Fourth CEMDC Course 2017-2019
For current and future pharma managers from all countries
Register now! Early bird allowance until July 31, 2017!
The 4th CEMDC course will start in Budapest October 2017. – The aim of the course is to train experts who understand the complex process of medicines development from molecule to health care and who can apply this knowledge working in large or small, innovative or generic pharmaceutical companies, regulatory agencies, in health care and health research or insurance management. The course material was carefully compiled by academic and industry experts to meet the needs of both the pharmaceutical industry and health care. It covers the 3 main competency areas of medicines development: Drug Development and Clinical Trials; Regulatory Affairs and Safety of Medicines; Health Care and Professionalism. The teaching follows the international, harmonized modular training program and quality standards developed by PharmaTrain. The CEMDC is internationally accredited as a PharmaTrain Center of Excellence. The entire Base Diploma Course contains 8 modules. Certain modules might be presented at other participating universities. Each module lasts 4 days and is finished by an examination. The modules are given in 2-3 month intervals. It is possible to visit only selected modules to satisfy individual educational needs. Students can apply with medical, pharmaceutical, MSc or equivalent degrees in natural and life sciences. The course is open for students of all nationalities. The official language of the course is English. Coordinated by the Semmelweis University, Budapest, Hungary. Participation fee
Modules of the 4th Course
MODULE 1a. INTRODUCTORY PROGRAMME & MODULE 1b. PRINCIPLES OF DISCOVERY OF MEDICINES AND DEVELOPMENT PLANNING
MODULE 2: NON-CLINICAL, PHARMACEUTICAL AND EARLY CLINICAL DEVELOPMENT
MODULE 3: CLINICAL DEVELOPMENT OF MEDICINES: EXPLORATORY AND CONFIRMATORY
MODULE 4: CLINICAL TRIALS
MODULE 5: REGULATORY AFFAIRS; DRUG SAFETY and PHARMACOVIGILANCE
MODULE 6: HEALTHCARE MARKETPLACE; ECONOMICS OF HEALTHCARE
MODULE 7: BIOLOGICALS AND ADVANCED THERAPIES
MODULE 8: GENERIC & BIOSIMILAR MEDICINAL PRODUCTS
All the CEMDC related activities are coordinated by the Semmelweis University, Budapest, Hungary CEMDC Cooperative European Medicines Development Course Semmelweis University, Department of Pharmacology and Pharmacotherapy
Nagyvárad tér 4. H-1089 Budapest, Hungary
Email: cemdc3@gmail.com
Website: www.semmeilweis.hu/cemdc
Study Director: Dr. S. Kerpel-Fronius, Email: kerpelfronius@gmail.com; mobile:+36204790380
Study Manager: Ms. Judit Lendvay, Email: cemdc3@gmail.com; mobile: +36304757366
Facebook: https://www.facebook.com/CooperativeEuropeanMedicinesDevelopmentCourse/